EichorEICHOR
Condition: Recurrent Malignant Germ Cell Tumor Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Recurrent Malignant Germ Cell Tumor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
Phase 1 · 1 location(s) · Henry Ford Health System · NCT05686798The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
Phase N/A · 8 location(s) · Erasmus Medical Center · NCT06273176Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Phase 1/Phase 2 · 21 location(s) · Children's Oncology Group · NCT04851119Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma
Phase 1 · 1 location(s) · NanoPharmaceuticals LLC · NCT05226494Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Ref
Phase 2 · 1 location(s) · Northwell Health · NCT02800486Sitagliptin in Recurrent/Progressive Grade 4 Glioma
Phase 1 · 1 location(s) · Kailin Yang, MD, PhD · NCT07541781Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Duc
Phase 1 · 1 location(s) · Radiomedix, Inc. · NCT07733674EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial
NA · 2 location(s) · Leiden University Medical Center · NCT06767332Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid
Phase 1 · 3 location(s) · Anusha Kalbasi · NCT04119024CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Phase 1/Phase 2 · 35 location(s) · Children's Oncology Group · NCT04870944Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
NA · 1 location(s) · Northwell Health · NCT05979064Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The K
Phase 4 · 1 location(s) · OHSU Knight Cancer Institute · NCT07405086A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) M
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05588141Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Phase 1/Phase 2 · 4 location(s) · Nationwide Children's Hospital · NCT05278208MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03896568The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06283927Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Phase 1 · 1 location(s) · Beijing Biotech · NCT07551336IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05039801LITT Followed by Hypofractionated RT for Recurrent Gliomas
NA · 4 location(s) · University of Maryland, Baltimore · NCT04181684Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma
Phase 1 · 1 location(s) · Darell Bigner · NCT04547777Evaluation of Clinical Efficacy and Safety of Specific Mode Electroacupuncture Stimulation for Paclitaxel Across BBB Del
Phase 2 · 1 location(s) · The Third Affiliated hospital of Zhejiang Chinese Medical Un · NCT06818331RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
Phase 1 · 1 location(s) · University of Florida · NCT06389591Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Phase 1/Phase 2 · 10 location(s) · St. Jude Children's Research Hospital · NCT04901702Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Phase 1 · 1 location(s) · Florida International University · NCT05857969CARv3-TEAM-E T Cells in Glioblastoma
Phase 1 · 1 location(s) · Marcela V. Maus, M.D.,Ph.D. · NCT05660369Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
NA · 8 location(s) · University of California, San Francisco · NCT05057702Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objective
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT01365169Chronic CED of TPT for Recurrent Malignant Glioma
Phase 1 · 1 location(s) · Jeffrey N. Bruce · NCT06666712Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
Phase 1 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT06964737A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Gliobl
Phase 1 · 2 location(s) · University of Florida · NCT04573140
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.